Christopher Robinson: Early Cytokine Signals in Amniotic Fluid Embolism
Christopher Robinson, Executive Chair at the Foundation for the Society for Maternal-Fetal Medicine, Associate Professor of Maternal-Fetal Medicine at the University of South Carolina, shared a post on LinkedIn about a recent article by Roberto Romero et al, published in American Journal of Obstetrics and Gynecology, adding:
“A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death – Plasma concentrations of cytokines in patients at term in labor and before the diagnosis of amniotic fluid embolism (blue asterisk) and at the time of diagnosis (red dot).”
Title: A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death
Authors: Roberto Romero, Arun Meyyazhagan, Dereje W. Gudicha, Tinnakorn Chaiworspongsa, Awoniyi O. Awonuga, Adi L. Tarca, Nardhy Gomez-Lopez, Sonia S. Hassan
Other posts featuring Christopher Robinson on Hemostasis Today.
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke
-
Oct 12, 2026, 07:28Beth Sara: IBMS Specialist Portfolio Achievement and a New Role in Transfusion Practice
-
Oct 12, 2026, 07:28Abdul Mannan: PCC vs. aPCC – The Small ‘a’ That Changes Emergency Management
-
Oct 12, 2026, 07:20Mokhtar Tazik: Improving Access to Plasma Derived Medicines Through Awareness, Interest and Accessibility